{"id":"W1989523897","doi":"10.1111/j.1365-2036.2012.05189.x","title":"Review article: non‐malignant haematological complications of anti‐tumour necrosis factor alpha therapy","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Cilag; UCB Pharma; Biogen; Sanofi; AstraZeneca; Genentech; Amgen","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Adverse effect; Internal medicine; Tumor necrosis factor alpha; Immunology; Gastroenterology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004581921,0.0009774556,0.001839252,0.00278109,0.000329863,0.001592796,0.0009971034,0.001473558,0.005856809],"category_scores_gemma":[0.002120242,0.0002127159,0.0008494346,0.004064534,0.0004346371,0.001197602,0.0005559206,0.001229655,0.001653008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008062626,"about_ca_system_score_gemma":0.001551343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000877062,"about_ca_topic_score_gemma":0.001084953,"domain_scores_codex":[0.9994256,0.0001125407,0.0001782736,0.00007653169,0.0001684962,0.00003858121],"domain_scores_gemma":[0.9986556,0.000647229,0.0003376056,0.00002400099,0.0002613067,0.0000742241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002099242,0.00009275263,0.0008717996,0.1524274,0.0005191247,0.002340748,0.0002037038,0.0003421284,0.0009163283,0.001169811,0.1959657,0.6449406],"study_design_scores_gemma":[0.00007450714,0.0001551496,0.003901255,0.04842438,0.0009748562,0.02192657,0.000213323,0.0001093771,0.0003736701,0.001022856,0.9227822,0.00004187647],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002273993,0.9968385,0.00005427526,0.0004253811,0.001412152,0.00001205337,0.00004331908,0.000005182546,0.0009818316],"genre_scores_gemma":[0.001450635,0.9951289,0.0001042385,0.0006434547,0.002064956,0.0000130792,0.00007638324,0.000002240716,0.0005161708],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005856809,"threshold_uncertainty_score":0.019593,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0958549959762631,"score_gpt":0.3878390665469855,"score_spread":0.2919840705707224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}